» Articles » PMID: 38758698

Interferon Signaling in the Nasal Epithelium Distinguishes Among Lethal and Common Cold Coronaviruses and Mediates Viral Clearance

Overview
Specialty Science
Date 2024 May 17
PMID 38758698
Authors
Affiliations
Soon will be listed here.
Abstract

All respiratory viruses establish primary infections in the nasal epithelium, where efficient innate immune induction may prevent dissemination to the lower airway and thus minimize pathogenesis. Human coronaviruses (HCoVs) cause a range of pathologies, but the host and viral determinants of disease during common cold versus lethal HCoV infections are poorly understood. We model the initial site of infection using primary nasal epithelial cells cultured at an air-liquid interface (ALI). HCoV-229E, HCoV-NL63, and human rhinovirus-16 are common cold-associated viruses that exhibit unique features in this model: early induction of antiviral interferon (IFN) signaling, IFN-mediated viral clearance, and preferential replication at nasal airway temperature (33 °C) which confers muted host IFN responses. In contrast, lethal SARS-CoV-2 and MERS-CoV encode antagonist proteins that prevent IFN-mediated clearance in nasal cultures. Our study identifies features shared among common cold-associated viruses, highlighting nasal innate immune responses as predictive of infection outcomes and nasally directed IFNs as potential therapeutics.

Citing Articles

Anti-interferon armamentarium of human coronaviruses.

Khatun O, Kaur S, Tripathi S Cell Mol Life Sci. 2025; 82(1):116.

PMID: 40074984 PMC: 11904029. DOI: 10.1007/s00018-025-05605-z.


The Unusual Role of Ribonuclease L in Innate Immunity.

Karasik A, Guydosh N Wiley Interdiscip Rev RNA. 2024; 15(6):e1878.

PMID: 39727035 PMC: 11672174. DOI: 10.1002/wrna.1878.

References
1.
Klinkhammer J, Schnepf D, Ye L, Schwaderlapp M, Gad H, Hartmann R . IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission. Elife. 2018; 7. PMC: 5953542. DOI: 10.7554/eLife.33354. View

2.
Voigt E, Yin J . Kinetic Differences and Synergistic Antiviral Effects Between Type I and Type III Interferon Signaling Indicate Pathway Independence. J Interferon Cytokine Res. 2015; 35(9):734-47. PMC: 4560852. DOI: 10.1089/jir.2015.0008. View

3.
Garcia-Sastre A, Egorov A, Matassov D, Brandt S, Levy D, Durbin J . Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology. 1999; 252(2):324-30. DOI: 10.1006/viro.1998.9508. View

4.
Becker T, Durrani S, Bochkov Y, Devries M, Rajamanickam V, Jackson D . Effect of exogenous interferons on rhinovirus replication and airway inflammatory responses. Ann Allergy Asthma Immunol. 2013; 111(5):397-401. PMC: 3845219. DOI: 10.1016/j.anai.2013.07.029. View

5.
Stolting H, Baillon L, Frise R, Bonner K, Hewitt R, Molyneaux P . Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1. Mucosal Immunol. 2022; 15(5):952-963. PMC: 9284972. DOI: 10.1038/s41385-022-00545-4. View